Golembiewski Michael Joseph 4
4 · SEELOS THERAPEUTICS, INC. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-29$1.10/sh+417$457→ 86,869 total
Footnotes (2)
- [F1]These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Effective on November 28, 2023, the Issuer conducted a reverse stock split at a ratio of 1-for-30 (the "Reverse Split"). The number of shares reported herein reflects the number of shares after the Reverse Split.